AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 274: E459-E468, 1998;
0193-1849/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salehi, A.
Right arrow Articles by Lundquist, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salehi, A.
Right arrow Articles by Lundquist, I.
Vol. 274, Issue 3, E459-E468, March 1998

Insulin release transduction mechanism through acid glucan 1,4-alpha -glucosidase activation is Ca2+ regulated

Albert Salehi, Henrik Mosén, and Ingmar Lundquist

Department of Pharmacology, University of Lund, S-223 62 Lund, Sweden

An important signal involved in glucose-stimulated insulin secretion is transduced through the action of a lysosomal acid, glucan 1,4-alpha -glucosidase. We investigated the Ca2+ dependency of this enzyme activity in relation to insulin release. In isolated islets, increased levels of extracellular Ca2+ induced a large increase in acid glucan 1,4-alpha -glucosidase activity accompanied by a similar increase in insulin release at both substimulatory and stimulatory concentrations of glucose. At low glucose the Ca2+ "inflow" blocker nifedipine unexpectedly stimulated enzyme activity without affecting insulin release. However, nifedipine suppressed 45Ca2+ outflow from perifused islets at low glucose and at Ca2+ deficiency when intracellular Ca2+ was mobilized by carbachol. This nifedepine-induced retention of Ca2+ was reflected in increased acid glucan 1,4-alpha -glucosidase activity. Adding different physiological Ca2+ concentrations or nifedipine to islet homogenates did not increase enzyme activity. Neither selective glucan 1,4-alpha -glucosidase inhibition nor the ensuing suppression of glucose-induced insulin release was overcome by a maximal Ca2+ concentration. Hence, Ca2+-induced changes in acid glucan 1,4-alpha -glucosidase activity were intimately coupled to similar changes in Ca2+-glucose-induced insulin release. Ca2+ did not affect the enzyme itself but presumably activated either glucan 1,4-alpha -glucosidase-containing organelles or closely interconnected messengers.

pancreatic islets; lysosomal enzymes; nifedipine; emiglitate; carbachol; calcium ion


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Henningsson, A. Salehi, and I. Lundquist
Role of nitric oxide synthase isoforms in glucose-stimulated insulin release
Am J Physiol Cell Physiol, July 1, 2002; 283(1): C296 - C304.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Salehi, B.-G. Fan, M. Ekelund, G. Nordin, and I. Lundquist
TPN-evoked dysfunction of islet lysosomal activity mediates impairment of glucose-stimulated insulin release
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E171 - E179.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online